A Meta-Analysis Comparing Lobectomy versus Segmentectomy in Stage I Non-Small Cell Lung Cancer
10.5090/kjtcs.2019.52.4.195
- Author:
Tae Yoon LIM
1
;
Samina PARK
;
Chang Hyun KANG
Author Information
1. Department of Anesthesiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Publication Type:Meta-Analysis
- Keywords:
Meta-analysis;
Non-small-cell lung carcinoma;
Lobectomy;
Segmentectomy;
Survival
- MeSH:
Carcinoma, Non-Small-Cell Lung;
Humans;
Mastectomy, Segmental;
Mortality;
Odds Ratio;
Survival Rate
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2019;52(4):195-204
- CountryRepublic of Korea
- Language:English
-
Abstract:
Lobectomy is considered the standard strategy for early-stage non-small cell lung cancer (NSCLC). However, sublobar resection for NSCLC has recently received increased attention. The objective of this study was to compare 5-year survival, recurrence-free survival, postoperative mortality, and postoperative morbidities in patients who received segmentectomy versus those who received lobectomy through a meta-analysis. Sixteen studies were included and the combined hazard ratios or odds ratios were calculated. The results revealed that the 5-year survival rate after segmentectomy was comparable to that of lobectomy for stage IA NSCLC. However, segmentectomy for stage I NSCLC had lower rates of postoperative mortality and morbidities than lobectomy.
